Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial

Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T18:59:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces an NIH website terminology transition, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:10:53.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:41:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A 403 Forbidden error is displayed for the study record, replacing the usual content and hiding the study documents and sections from view.
    Difference
    18%
    Check dated 2026-09-22T20:59:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The platform revision was updated from v3.6.6 to v3.7.0, indicating a deployment update.
    Difference
    0.0%
    Check dated 2026-09-15T20:49:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision metadata updated from v3.6.5 to v3.6.6. This reflects a newer release version on the site without changes to visible content.
    Difference
    0.0%
    Check dated 2026-09-01T19:42:50.000Z thumbnail image

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.